MarketInOut Stock Screener Log In | Sign Up

Sanofi India Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:58
Sanofi India Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization63,795 mln
Float8.48 mln
Earnings Date10/29/2026

EPS

141
Exceptional

P / E

21.98
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.19
Reliable

Relative Strength

91 / 100
Top performer

Debt / Equity

0.02
Debt-free

Business Description

Sanofi India Limited is a Mumbai-based pharmaceutical company that develops and sells medicines across a wide range of health conditions, including diabetes, heart disease, infections, and pain management. Operating under well-known brand names such as Lantus, Combiflam, Allegra, and Enterogermina, the company distributes its products throughout India and exports to around 24 countries worldwide. Founded in 1956 and formerly known as Aventis Pharma Limited, it operates as a subsidiary of Hoechst GmbH.

Key Fundamentals

EPS141
P/E21.98
ROE41.21
RPS784
ROIC48.97
ROA24.68
Interest Cover282
EBITDA, mln4,736
EV / EBITDA14.19
EV / EBIT15.37
Revenue, mln18,052
EV / Revenue3.72

Quote Details

Last 3,090.00
Change 252.35 (8.89%)
Open 2,837.70
Volume 1,981
Turnover 6,121,290
Average Volume 1,482

Financial Ratios

Pre-Tax Profit Margin24
Leverage Ratio1.70
Current Ratio1.69
Price / Book8.53
Price / Tangible Book8.54
Price / Cash Flow44.00
Price / Free Cash Flow16.56
Debt / Equity0.02
Price / Sales3.90
PEG Ratio1.48

Financial Strength

Altman Z-Score9.94
Piotroski F-Score 6 / 9
Beneish M-Score-3.19
Price to Intrinsic Value1.42
Price to Graham Number2.78
Shiller PE Ratio11.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.19% 95 / 100   
1 Month -2.16% 72 / 100   
2 Months -9.3% 45 / 100   
6 Months -9.79% 45 / 100   
1 Year -32.19% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog